Peapack-Gladstone Financial Corp’s ANI Pharmaceuticals ANIP Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$769K	Hold	10,000	–	–	0.01%	426
2025 Q4	$789K	Hold	10,000	–	–	0.01%	422
2025 Q3	$916K	Hold	10,000	–	–	0.01%	418
2025 Q2	$653K	Hold	10,000	–	–	0.01%	446
2025 Q1	$670K	Hold	10,000	–	–	0.01%	436
2024 Q4	$553K	Hold	10,000	–	–	0.01%	464
2024 Q3	$597K	Hold	10,000	–	–	0.01%	457
2024 Q2	$637K	Hold	10,000	–	–	0.01%	443
2024 Q1	$691K	Hold	10,000	–	–	0.01%	438
2023 Q4	$551K	Hold	10,000	–	–	0.01%	468
2023 Q3	$581K	Hold	10,000	–	–	0.01%	449
2023 Q2	$538K	Hold	10,000	–	–	0.01%	469
2023 Q1	$397K	Hold	10,000	–	–	0.01%	515
2022 Q4	$402K	Hold	10,000	–	–	0.01%	497
2022 Q3	$321K	Hold	10,000	–	–	0.01%	533
2022 Q2	$297K	Hold	10,000	–	–	0.01%	517
2022 Q1	$281K	Buy	+10,000	New	+$373K	0.01%	569

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Peapack-Gladstone Financial Corp's ANIP Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp held its ANI Pharmaceuticals (ANIP) position steady in Q1 2026 at 10,000 shares worth $769K. The position accounts for 0.01% of the portfolio, ranked #426.

Peapack-Gladstone Financial Corp first reported a position in ANIP in Q1 2022 and has held it in 17 quarters since. The position peaked at $916K in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

Peapack-Gladstone Financial Corp held 10,000 shares of ANI Pharmaceuticals worth $769K as of Q1 2026.
Peapack-Gladstone Financial Corp left its ANI Pharmaceuticals share count unchanged in Q1 2026.
ANI Pharmaceuticals made up 0.01% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #426 holding.
Peapack-Gladstone Financial Corp first reported a position in ANI Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
Peapack-Gladstone Financial Corp's ANI Pharmaceuticals position peaked at $916K in Q3 2025.
280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.